{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:59:12Z","timestamp":1758052752949,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.clinbiochem.2004.10.001","type":"journal-article","created":{"date-parts":[[2004,11,13]],"date-time":"2004-11-13T11:59:08Z","timestamp":1100347148000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis"],"prefix":"10.1016","volume":"38","author":[{"given":"Ali","family":"Gur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Colpan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remzi","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Nas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Jale Sarac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clinbiochem.2004.10.001_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0009-9120(97)00113-6","article-title":"Biochemical markers of bone metabolism: an overview","volume":"30","author":"Christenson","year":"1997","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.clinbiochem.2004.10.001_bib2","first-page":"358","article-title":"Osteoporosis and the role of diet","volume":"51","author":"Eaton-Evans","year":"1994","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib3","first-page":"23","article-title":"Low serum copper, a risk factor additional to low dietary calcium in postmenopausal bone loss","volume":"5","author":"Howard","year":"1992","journal-title":"J. Trace Elem. Exp. Med."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib4","series-title":"Clinical chemistry. Theory, analysis, and correlation","first-page":"528","article-title":"Bone disease","author":"Itan","year":"1996"},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00003086-197409000-00084","article-title":"The role of zinc in bone metabolism","volume":"103","author":"Calhoun","year":"1974","journal-title":"Orthopedics"},{"issue":"6","key":"10.1016\/j.clinbiochem.2004.10.001_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1248\/bpb.17.862","article-title":"Histomorphological confirmation of the preventive effect of beta-alanyl-l-histidinato zinc on bone loss in ovariectomized rats","volume":"17","author":"Kishi","year":"1994","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.clinbiochem.2004.10.001_bib7","first-page":"203","article-title":"Prolonged administration of beta-alanyl-l-histidinato zinc prevents bone loss in on the deterioration ovariectomized rats","volume":"63","author":"Yamaguchi","year":"1993","journal-title":"Jpn. J. Biopharmacol."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s774-002-8445-y","article-title":"The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin","volume":"20","author":"Gur","year":"2002","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF01623829","article-title":"Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption","volume":"3","author":"Eastell","year":"1993","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib10","first-page":"1693","article-title":"Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment","volume":"79","author":"Garnero","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib11","first-page":"37","article-title":"Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women","volume":"81","author":"Raisz","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-8981(98)00172-7","article-title":"Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis","volume":"279","author":"Parvainen","year":"1999","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(90)90089-V","article-title":"Discontinuous calcitonin treatment of established osteoporosis\u2014Effects of withdrawal of treatment","volume":"89","author":"Overgaard","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jbmr.5650050308","article-title":"Zinc excretion in osteoporotic women","volume":"5","author":"Herzbeg","year":"1990","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0924-2244(99)00052-7","article-title":"Functional food ingredients for reducing the risks of osteoporosis","volume":"11","author":"Brouns","year":"2000","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/ageing\/24.4.303","article-title":"Zinc biochemical markers of nutrition, and type 1 osteoporosis","volume":"24","author":"Relea","year":"1995","journal-title":"Age Ageing"},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib17","first-page":"129","article-title":"Blood zinc findings in osteoporosis","volume":"126","author":"Steidl","year":"1990","journal-title":"Acta Univ. Palacki. Olomuc., Fac. Med."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib18","first-page":"281","article-title":"Relation of magnesium to osteoporosis and calcium urolithiasis","volume":"10","author":"Wallach","year":"1991","journal-title":"Magnes. Trace Elem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2004.10.001_bib19","first-page":"51","article-title":"Biochemical findings in osteoporosis: I. The significance of magnesium","volume":"12 129","author":"Steidl","year":"1990","journal-title":"Cas. Leck. Cesk."},{"issue":"12","key":"10.1016\/j.clinbiochem.2004.10.001_bib20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/0026-0495(94)90002-7","article-title":"Copper deficiency secondary to a copper transport defect: a new copper metabolic disturbance","volume":"43","author":"Bunchman","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib21","unstructured":"Colpan L, Gur A, Cevik R, Nas K, Sarac AJ. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis: a double-blind and placebo-controlled trial. Maturitas (in press)."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0009-8981(99)00151-5","article-title":"Comparison of biochemical markers of bone remodeling in the assessment of the effects of alendronate on bone in postmenopausal osteoporosis","volume":"288","author":"Stepan","year":"1999","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9343(96)00387-7","article-title":"Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effects and predicts response of bone mineral density","volume":"102","author":"Chesnut","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S8756-3282(99)00087-3","article-title":"A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover","volume":"24","author":"Garnero","year":"1999","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.clinbiochem.2004.10.001_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S8756-3282(03)00168-6","article-title":"Biochemical markers for prediction of 4-year response in bone mass during bisphosphanate treatment for prevention of postmenopausal osteoporosis","volume":"33","author":"Ravn","year":"2003","journal-title":"Bone"},{"issue":"22","key":"10.1016\/j.clinbiochem.2004.10.001_bib26","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1001\/archinte.1997.00440430099012","article-title":"Treatment with alendronate prevents fractures in women at highest risk: results from the fracture intervention trial","volume":"157","author":"Ensrud","year":"1997","journal-title":"Arch. Intern. Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2004.10.001_bib27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1359\/jbmr.2000.15.8.1537","article-title":"The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women","volume":"15","author":"Chaki","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib28","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.1999.14.8.1404","article-title":"Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures","volume":"14","author":"Bauer","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5122(03)00084-7","article-title":"Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women","volume":"45","author":"Garcia-Perez","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.clinbiochem.2004.10.001_bib30","first-page":"3537","article-title":"Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type I predict long-term response to alendronate therapy in elderly women","volume":"85","author":"Greenspan","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.clinbiochem.2004.10.001_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"A multinational randomized trial of the effects of alendronate on bone mineral density and fracture risk in postmenopausal women with low bone mass: result of the FOSIT study","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos. Int."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991200400284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991200400284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:21:35Z","timestamp":1757863295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991200400284X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S000991200400284X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.10.001","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}